• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Soaring Eagle Acquisition Corp.

    9/27/21 5:29:26 PM ET
    $SRNG
    Get the next $SRNG alert in real time by email
    SC 13G 1 eh210187261_13g-ginkgo.htm SCHEDULE 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

    Ginkgo Bioworks Holdings, Inc.
    (Name of Issuer)
     
    Class A common stock, par value $0.0001 per share
    (Title of Class of Securities)
     
    37611X100
    (CUSIP Number)
     
    September 16, 2021
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐ Rule 13d-1(b)
      ☒ Rule 13d-1(c)
      ☐ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 2 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    General Atlantic, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 3 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    General Atlantic Partners 100, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 4 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    General Atlantic Partners (Bermuda) EU, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Bermuda

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 5 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    GAP Coinvestments III, LLC

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 6 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    GAP Coinvestments IV, LLC

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 7 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    GAP Coinvestments V, LLC

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 8 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    GAP Coinvestments CDA, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 9 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    General Atlantic (SPV) GP, LLC

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 10 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    General Atlantic GenPar (Bermuda), L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Bermuda

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 11 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    General Atlantic GenPar, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Bermuda

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 12 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    General Atlantic (GK), L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 13 of 23

     

     

    1

    NAME OF REPORTING PERSON

     

    GAP (Bermuda) L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Bermuda

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    114,836,660

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    114,836,660

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    114,836,660 (1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    8.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

    (1) Includes 12,276,793 earn-out shares that will vest in four substantially equal installments if the common shares achieve a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds $12.50, $15.00, $17.50 and $20.00, which vesting is subject to acceleration in the event of a change of control transaction if the consideration received by Ginkgo’s shareholders is greater than or equal to the earn-out targets.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 14 of 23

     

     

    Item 1. (a) NAME OF ISSUER
         
        Ginkgo Bioworks Holdings, Inc. (the “Company”).
         
      (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
         
        27 Drydock Avenue, 8th Floor, Boston, Massachusetts 02210.
         
    Item 2. (a) NAMES OF PERSONS FILING

     

    This Statement is being filed on behalf of each of the following persons (collectively, the “Reporting Persons”): 

         
      (i) General Atlantic, L.P. (“GA LP”)
         
      (ii) General Atlantic Partners 100, L.P. (“GAP 100”);
         
      (iii) General Atlantic Partners (Bermuda) EU, L.P. (“GAP Bermuda EU”);
         
      (iv) GAP Coinvestments III, LLC (“GAPCO III”);
         
      (v) GAP Coinvestments IV, LLC (“GAPCO IV”);
         
      (vi) GAP Coinvestments V, LLC (“GAPCO V”);
         
      (vii) GAP Coinvestments CDA, L.P. (“GAPCO CDA”);
         
      (viii) General Atlantic (SPV) GP, LLC (“GA SPV”);
         
      (ix) General Atlantic GenPar (Bermuda), L.P. (“GenPar Bermuda”)
         
      (x) General Atlantic GenPar, L.P. (“GA GenPar”)
         
      (xi) General Atlantic (GK), L.P. (“GA GK”);
         
      (xii) GAP (Bermuda) L.P. (“GAP Bermuda”);

     

    GAP 100, GAP Bermuda EU, GAPCO III, GAPCO IV, GAPCO V, and GAPCO CDA are collectively referred to as the “GA Funds.”

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 15 of 23

     

     

      (b) ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE

     

    The mailing address of GA LP, GAP 100, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GA GenPar, GA SPV and GA GK is c/o General Atlantic Service Company, L.P., 55 East 52nd Street, 33rd Floor, New York, NY 10055. The mailing address of GAP Bermuda EU, GenPar Bermuda and GAP Bermuda is Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda.

     

      (c) CITIZENSHIP

     

      (i) GA LP - Delaware
         
      (ii) GAP 100 - Delaware
         
      (iii) GAP Bermuda EU - Bermuda
         
      (iv) GAPCO III - Delaware
         
      (v) GAPCO IV - Delaware
         
      (vi) GAPCO V - Delaware
         
      (vii) GAPCO CDA - Delaware
         
      (viii) GA SPV - Delaware
         
      (ix) GenPar Bermuda - Bermuda
         
      (x) GA GenPar - Delaware
         
      (xi) GA GK - Delaware
         
      (xii) GAP Bermuda - Bermuda
         
      (d) TITLE OF CLASS OF SECURITIES
         

    Class A common stock, par value $0.0001 per share (the “common shares”).

     

      (e) CUSIP NUMBER

     

    37611X100.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 16 of 23

     

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS:

     

    Not applicable.

     

    Item 4. OWNERSHIP.

     

    As of September 27, 2021, the Reporting Persons owned the following number of the Company’s common stock:

     

      (i) GA LP owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (ii) GAP 100 owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (iii) GAP Bermuda EU owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (iv) GAPCO III owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (v) GAPCO IV owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (vi) GAPCO V owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (vii) GAPCO CDA owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (viii) GA SPV owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (ix) GenPar Bermuda owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (x) GA GenPar owned of record no common shares or 0.0% of the issued and outstanding common shares
         
      (xi) GA GK owned of record 114,836,660 common shares or 8.6% of the issued and outstanding common shares
         
      (xii) GAP Bermuda owned of record no common shares or 0.0% of the issued and outstanding common shares

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 17 of 23

     

     

    The GA Funds share beneficial ownership of the common shares held by GA GK. The general partner of GA GK is GA SPV. The general partner of GAP 100 is GA GenPar. The general partner of GAP Bermuda EU is GenPar Bermuda. GA LP, which is controlled by the Management Committee of GASC MGP, LLC (the “Management Committee”), is the managing member of GAPCO III, GAPCO IV and GAPCO V, the general partner of GAPCO CDA and GA GenPar, and the sole member of GA SPV. The general partner of GenPar Bermuda is GAP Bermuda, which is also controlled by the Management Committee. There are nine members of the Management Committee. By virtue of the foregoing, the Reporting Persons may be deemed to share voting power and the power to direct the disposition of the shares that each owns of record. Each of the members of the Management Committee disclaims ownership of the common shares reported herein except to the extent he or she has a pecuniary interest therein. The name, the business address and the citizenship of each of the members of the Management Committee as of the date hereof is attached hereto as Schedule A and is hereby incorporated by reference.

     

    Amount Beneficially Owned:

     

    By virtue of the relationship described above, each of the Reporting Persons may be deemed to beneficially own 114,836,660 common shares.

     

    Percentage Owned:

     

    All calculations of percentage ownership herein are based on an aggregate of 1,341,378,910 common shares, the sum of (i) 1,329,102,117 common shares reported by the Company to be outstanding following the consummation of the merger transaction with Soaring Eagle Acquisition Corp,. as reflected in the Company’s Prospectus filed under Rule 424(b)(3), filed with the U.S. Securities and Exchange Commission on September 16, 2021 and (ii) 12,276,793 earn-out shares beneficially owned by the Reporting Persons.

     

    Number of Shares as to Which Such Person Has Sole/Shared Power to Vote or to Direct the Vote and Sole/Shared Power to Dispose or to Direct the Disposition of:

     

    (i) Each of the Reporting Persons may be deemed to have the sole power to direct the voting and dispositions of the common shares as indicated on such Reporting Person’s cover page included herein.

     

    (ii) Each of the Reporting Persons may be deemed to share the power to direct the voting and dispositions of the 114,836,660 common shares that may be deemed to be owned beneficially by each of them.

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

     

    Not applicable.

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 18 of 23

     

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

     

    Not applicable.

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

     

    Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

     

    See Item 4, which states the identity of the members of the group filing this Schedule 13G.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP

     

    Not applicable.

     

    Item 10. CERTIFICATION

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 19 of 23

     

     

    Exhibit Index

     

    Exhibit 1. Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

     

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 20 of 23

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated as of September 27, 2021

     

     

      GENERAL ATLANTIC, L.P.  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GENERAL ATLANTIC PARTNERS 100, L.P.  
           
      By: GENERAL ATLANTIC GENPAR, L.P., its general partner  
           
      By: GENERAL ATLANTIC, L.P., its general partner  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             
             
      GENERAL ATLANTIC PARTNERS (BERMUDA) EU, L.P.  
             
      By: GENERAL ATLANTIC GENPAR (BERMUDA), L.P., its general partner  
           
      By: GAP (BERMUDA) L.P., its general partner  
           
      By: GAP (BERMUDA) GP LIMITED, its general partner  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 21 of 23

     

     

      GAP COINVESTMENTS III, LLC  
             
      By: GENERAL ATLANTIC, L.P., its managing member   
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GAP COINVESTMENTS IV, LLC  
             
      By: GENERAL ATLANTIC, L.P., its managing member   
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             
             
      GAP COINVESTMENTS V, LLC  
             
      By: GENERAL ATLANTIC, L.P., its managing member  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             
         
      GAP COINVESTMENTS CDA, L.P.  
             
      By: GENERAL ATLANTIC, L.P., its general partner  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 22 of 23

     

     

      GENERAL ATLANTIC (SPV) GP, LLC  
             
      By: GENERAL ATLANTIC, L.P., its sole member  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GENERAL ATLANTIC GENPAR (BERMUDA), L.P.  
             
      By: GAP (BERMUDA) L.P., its general partner  
           
      By:

    GAP (BERMUDA) GP LIMITED, its general partner

     
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GENERAL ATLANTIC GENPAR, L.P.  
             
      By: GENERAL ATLANTIC, L.P., its general partner  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

      

     

     

    CUSIP No. 37611X100 SCHEDULE 13G Page 23 of 23

     

     

      GENERAL ATLANTIC (GK), L.P.  
             
     

    By:

     

    GENERAL ATLANTIC (SPV) GP, LLC, its general partner

     
           
      By: GENERAL ATLANTIC, L.P., its sole member  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
         

     

      GAP (BERMUDA) L.P.  
             
      By:

    GAP (BERMUDA) GP LIMITED, its general partner

     
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

     

      

     

     

    SCHEDULE A

    Members of the Management Committee (as of the date hereof)

     

    Name Business Address Citizenship

    William E. Ford

    (Chief Executive Officer)

    55 East 52nd Street

    33rd Floor

    New York, New York 10055

    United States
    Gabriel Caillaux

    23 Savile Row

    London W1S 2ET

    United Kingdom

    France
    Andrew Crawford

    55 East 52nd Street

    33rd Floor

    New York, New York 10055

    United States
    Martin Escobari

    55 East 52nd Street

    33rd Floor

    New York, New York 10055

    Bolivia and Brazil
    Anton J. Levy

    55 East 52nd Street

    33rd Floor

    New York, New York 10055

    United States
    Sandeep Naik

    Asia Square Tower 1

    8 Marina View, #41-04

    Singapore 018960

    United States
    Graves Tompkins

    55 East 52nd Street

    33rd Floor

    New York, New York 10055

    United States
    N. Robbert Vorhoff

    55 East 52nd Street

    33rd Floor

    New York, New York 10055

    United States
    Eric Zhang

    Suite 5704-5706, 57F

    Two IFC, 8 Finance Street

    Central, Hong Kong, China

    Hong Kong SAR

     

     

     

     

      

     

     

    EXHIBIT 1

     

    JOINT ACQUISITION STATEMENT

    PURSUANT TO RULE 13D-1(k)(1)

     

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is accurate.

     

    Dated as of September 27, 2021

     

     

      GENERAL ATLANTIC, L.P.  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GENERAL ATLANTIC PARTNERS 100, L.P.  
           
      By: GENERAL ATLANTIC GENPAR, L.P., its general partner  
           
      By: GENERAL ATLANTIC, L.P., its general partner  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             
             
      GENERAL ATLANTIC PARTNERS (BERMUDA) EU, L.P.  
             
      By: GENERAL ATLANTIC GENPAR (BERMUDA), L.P., its general partner  
           
      By: GAP (BERMUDA) L.P., its general partner  
           
      By: GAP (BERMUDA) GP LIMITED, its general partner  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             

     

      

     

     

      GAP COINVESTMENTS III, LLC  
             
      By: GENERAL ATLANTIC, L.P., its managing member   
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GAP COINVESTMENTS IV, LLC  
             
      By: GENERAL ATLANTIC, L.P., its managing member   
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             
             
      GAP COINVESTMENTS V, LLC  
             
      By: GENERAL ATLANTIC, L.P., its managing member  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             
         
      GAP COINVESTMENTS CDA, L.P.  
             
      By: GENERAL ATLANTIC, L.P., its general partner  
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
             

     

      

     

     

      GENERAL ATLANTIC (SPV) GP, LLC  
             
      By: GENERAL ATLANTIC, L.P., its sole member  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GENERAL ATLANTIC GENPAR (BERMUDA), L.P.  
             
      By: GAP (BERMUDA) L.P., its general partner  
           
      By:

    GAP (BERMUDA) GP LIMITED, its general partner

     
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      GENERAL ATLANTIC GENPAR, L.P.  
             
      By: GENERAL ATLANTIC, L.P., its general partner  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

      

     

     

      GENERAL ATLANTIC (GK), L.P.  
           
     

    By:

     

    GENERAL ATLANTIC (SPV) GP, LLC, its general partner

     
           
      By: GENERAL ATLANTIC, L.P., its sole member  
           
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  
         

     

      GAP (BERMUDA) L.P.  
             
      By:

    GAP (BERMUDA) GP LIMITED, its general partner

     
             
      By: /s/ Michael Gosk  
        Name: Michael Gosk  
        Title: Managing Director  

     

     

      

     

    Get the next $SRNG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRNG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRNG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3: New insider Cascade Investment, L.L.C. claimed ownership of 151,865,481 units of Class A Common Stock

    3 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Issuer)

    9/24/21 4:24:22 PM ET
    $SRNG

    SEC Form 3: New insider Viking Global Investors Lp claimed ownership of 339,055,144 units of Class A Common Stock

    3 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Issuer)

    9/23/21 4:11:12 PM ET
    $SRNG

    SEC Form 4: Eagle Equity Partners Iii, Llc returned 11,534,052 units of Class A Common Stock to the company, decreasing direct ownership by 27% to 31,590,948 units

    4 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Issuer)

    9/22/21 9:57:03 PM ET
    $SRNG

    $SRNG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ginkgo Bioworks to Go Public with Over $1.6 Billion in Proceeds

    Soaring Eagle Shareholder Approval Obtained, Closing Scheduled for September 16, 2021 Ginkgo Set to Begin Trading under NYSE: DNA on September 17, 2021 $1.633 billion in proceeds from the business combination represents the largest-ever biotechnology go-public transaction. Investors were led by Baillie Gifford, Putnam Investments, and funds and accounts managed by Counterpoint Global (Morgan Stanley Investment Management). Additional investors included ARK Investment Management LLC, ArrowMark Partners, Bain Capital Public Equity, Cascade Investment, Casdin Capital, Franklin Advisers, T. Rowe Price, and Viking Global Investors. Business combination with Ginkgo approved by Soaring Eagl

    9/14/21 9:13:00 AM ET
    $SRNG

    Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States

    BOSTON and ADDIS ABABA, Ethiopia, Sept. 14, 2021 /PRNewswire/ -- The Africa Centres for Disease Control and Prevention (Africa CDC), a specialized technical institution of the African Union, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to bolster the laboratory network capacity for African Union Member States. The partnership is aimed at supporting the continent's public health institutions with appropriate tools, training, and data infrastructure to leverage critical genomic sequencing technologies that will be implemented through Africa CDC Institute for Pathogen Genomics (IPG) and Ginkgo Bioworks.  Gin

    9/14/21 7:58:00 AM ET
    $SRNG

    Concentric by Ginkgo Stands Ready to Continue Fighting Pandemic, Providing Biosecurity and COVID Testing Nationwide to Schools, Workplaces, and Other Congregate Settings

    BOSTON, Sept. 10, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced its readiness to continue scaling support for COVID testing in congregate settings in response to new emergency standards and recommendations issued by the Biden-Harris Administration. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (NASDAQ:SRNG), serves customers across industries seeking to develop new and better products using biology. Last year, Ginkgo launched Concentric by Ginkgo, its public health and biosecurity initiative, to provide a response to the COVID-19 pandemic. Since then, Conc

    9/10/21 3:00:00 PM ET
    $SRNG

    $SRNG
    SEC Filings

    View All

    SEC Form EFFECT filed by Soaring Eagle Acquisition Corp.

    EFFECT - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    9/21/21 12:15:16 AM ET
    $SRNG

    SEC Form 424B3 filed by Soaring Eagle Acquisition Corp.

    424B3 - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    9/20/21 5:24:23 PM ET
    $SRNG

    Soaring Eagle Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Material Modification to Rights of Security Holders, Other Events, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status

    8-K - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    9/20/21 5:19:07 PM ET
    $SRNG

    $SRNG
    Financials

    Live finance-specific insights

    View All

    Ginkgo Bioworks Announces Date of First Half 2021 Results Presentation

    BOSTON, Aug. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (NASDAQ:SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. ET. The presentation will include an overview of first half performance, recent updates, and a discussion on Ginkgo's business model and outlook. The presentation details and registration link will be available on Ginkgo's investor relation

    8/9/21 7:00:00 AM ET
    $SRNG

    $SRNG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Soaring Eagle Acquisition Corp. (Amendment)

    SC 13D/A - Ginkgo Bioworks Holdings, Inc. (0001830214) (Subject)

    10/1/21 5:02:37 PM ET
    $SRNG

    SEC Form SC 13G filed by Soaring Eagle Acquisition Corp.

    SC 13G - Ginkgo Bioworks Holdings, Inc. (0001830214) (Subject)

    9/28/21 4:31:04 PM ET
    $SRNG

    SEC Form SC 13G filed by Soaring Eagle Acquisition Corp.

    SC 13G - Ginkgo Bioworks Holdings, Inc. (0001830214) (Subject)

    9/27/21 5:29:26 PM ET
    $SRNG